BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6860368)

  • 1. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
    Larrey D; Tinel M; Pessayre D
    Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
    Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
    J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
    Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
    J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions and hepatitis produced by some macrolide antibiotics.
    Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
    Pessayre D
    Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
    Lindstrom TD; Hanssen BR; Wrighton SA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interaction of rat liver cytochromes P-450 with erythromycin, oleandomycin and erythralosamine derivatives. Importance of structural factors.
    Sartori E; Delaforge M; Mansuy D
    Biochem Pharmacol; 1989 Jul; 38(13):2061-8. PubMed ID: 2735945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
    Delaforge M; Sartori E; Mansuy D
    Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics.
    Kitada M; Igoshi N; Kamataki T; Itahashi K; Imaoka S; Komori M; Funae Y; Rikihisa T; Kanakubo Y
    Arch Biochem Biophys; 1988 Jul; 264(1):61-6. PubMed ID: 3395131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450.
    Amacher DE; Schomaker SJ; Retsema JA
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1186-90. PubMed ID: 1656856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of erythromycin, oleandomycin and erythralosamine derivatives on hepatic cytochrome P-450.
    Delaforge M; Sartori E
    Biochem Pharmacol; 1990 Jul; 40(2):223-8. PubMed ID: 2375764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of macrolide antibiotics on barbiturate sleeping time in mice.
    Descotes J; Evreux JC
    Experientia; 1983 Dec; 39(12):1389-90. PubMed ID: 6606586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16 alpha-pregnenolone carbonitrile.
    Sartori E; Delaforge M; Mansuy D; Beaune P
    Biochem Biophys Res Commun; 1985 May; 128(3):1434-9. PubMed ID: 3873941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
    Delaforge M; Jaouen M; Mansuy D
    Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of erythromycin on hepatic drug-metabolizing enzymes in humans.
    Larrey D; Funck-Brentano C; Breil P; Vitaux J; Theodore C; Babany G; Pessayre D
    Biochem Pharmacol; 1983 Mar; 32(6):1063-8. PubMed ID: 6838653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.